Ginsen-1 capsule, the main ingredient is ginsenoside. This product has the effect of cultivating energy and tonifying qi and blood. Used in conjunction with chemotherapy, it helps to improve the therapeutic effect of primary lung cancer and hepatocellular carcinoma, improves the symptoms of qi deficiency in tumor patients, and enhances the immune function of the body. Its adverse reactions include dryness of mouth and throat, oral ulcers in a few patients after taking the drug. Sore throat, dizziness, tinnitus, nosebleed, chest tightness, dreamy, etc. may occur if overdose. In the phase I clinical trial, there was one case of mild transaminase abnormality in the high-dose group during the administration of the drug, but it is not certain whether it is related to the administration of this product, so it is recommended that patients take regular laboratory tests during the administration of this product. Contraindications to this product are unclear. It should be noted that it should be used with caution in cases of fire-heat syndrome or Yin deficiency and internal heat syndrome. It should not be used by those who have bleeding tendency. This product should be taken under the guidance of a medical professional and should not be taken on its own to avoid risks.